Purpose: To evaluate quality of life in patients with established rheumatoid arthritis (RA) and identify the factors that negatively affect it. Methods: This was a cross-sectional study with patients with established RA from a rheumatology center in Ecuador. The RA Quality of Life (RAQoL) questionnaire was used to assess QoL and the Health Assessment Questionnaire -disability index (HAQ-DI) questionnaire for functional capacity. In addition, demographics, clinical characteristics, and markers of disease activity were included. Data were analyzed using SPSS 22. Results: Of 186 patients, 89.8% were women, with a mean age of 51 years, 86.6% had symmetrical polyarticular involvement, 40.3% erosions, 46.8% morning stiffness, 46.8% xerophthalmia, and 39.2% fatigue. Depression was the most frequent comorbidity -42.5%. The mean HAQ-DI score was 0.8, and 26.9% had functional disability. The mean RAQoL score was 7.2. Xerophthalmia, xerostomia, fatigue, morning stiffness, and depression were related to higher scores in the RAQoL (p<0.05). The mean RAQoL was higher in patients with more disease activity and comorbidities (p<0.05). Likewise, patients with functional disability had a mean RAQoL score of 15.6 versus 4.1 in patients without disability (p<0.05). There were positive correlations between RAQoL and ESR, CRP, painful-joint count, swollen-joint count, VAS of pain, and physician assessment (p<0.05). Conclusion: QoL is severely affected in patients with RA. Depression, fatigue, morning stiffness, pain, high disease activity, and disability have a negative effect on QoL in RA. Likewise, patients with more comorbidities and extraarticular manifestations show worse QoL.
Introduction
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation that can ultimately lead to destruction and deformity. 1 RA is also a systemic disease, and most patients have extraarticular manifestations, such as weight loss, nodules, and fatigue, among others. 2 Disease-modifying drugs help to control disease progression; however, quality of life (QoL) in patients with RA is still severely affected. 3 Haroon et al 4 showed that patients with RA have worse QoL compared to normal controls. Other studies have shown that quality of life in patients with RA is lower than that of patients with other inflammatory diseases such as psoriatic arthritis, ankylosing spondylitis and systemic lupus erythematosus. 5, 6 Overall, the physical component of QoL is the most affected in RA due to bodily pain and limitations in physical functioning. 5 Groessl et al 7 showed that female sex, lower level of education, low socioeconomic status, being unemployed, and being single were significantly associated with lower QoL in patients with RA. In a study by Minkin, 8 the most important predictors of QoL were pain severity and depression. Another study showed a correlation between QoL and disease activity, duration of disease, functional capacity, and radiological damage. 9 Bedi et al 10 demonstrated extra-articular manifestations have greater impact on QoL. Likewise, a greater number of comorbidities have been associated with worse QoL in patients with RA.
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There are several scales to assess QoL. The most commonly used are the European QoL -5 Dimensions, the Nottingham Health Profile, and the Short Form 36 Survey. [12] [13] [14] These questionnaires are meant to be applied in the general population, as they are not sensitive to changes in the clinical status of patients with RA. 15 Conversely, the RAQoL questionnaire has shown good reliability and sensitivity to discriminate between groups with varying severity of disease activity. 16 This questionnaire is scored 0-30 based on dimensions that include energy, mobility, self-care, emotion, mood, and physical contact, with a lower score indicating better QoL. 17 The importance of studying QoL in patients with RA lies in its relationship with health care-resource utilization. Ethgen et al 18 
Methods
A cross-sectional study was carried out from January 2016 to January 2017. We included patients who attended a rheumatology center in the city of Guayaquil according to:
1. established diagnosis of RA according to the criteria of the American College of Rheumatology (1987) 2. age >18 years 3. agreement to participate in the study.
Patients with other inflammatory diseases or disabilities were excluded. Prior to participating in the study, patients provided written informed consent.
Data were collected using surveys that were filled out by the patients. The survey included demographics, characteristics of joint disease, VAS for pain, extra-articular manifestations, comorbidities, and treatment. A rheumatologist examined the patients to complete information about swollen-and painful-joint counts, presence of erosions on radiography, presence of rheumatoid nodules, and a VAS for general physician assessment.
Patients' medical records were reviewed to obtain the most recent levels of CRP and erythrocyte-sedimentation rate (ESR). Using these data, we calculated the diseaseactivity score (DAS) 28 -ESR using the program DAS28 Calculator version 1.1, available online at https:// www.das-score.nl/das28/DAScalculators/DAS28_3VAR. html. Remission was defined as a DAS28 score <2.6, low disease activity <3.2, moderate activity 3.2-5.1, and high activity >5.1.
We assessed QoL using the Spanish version of the RAQoL questionnaire. 19 In addition, patients filled out two more questionnaires: the Health Assessment Questionnaire -disability index (HAQ-DI) 20 to assess functional capacity and the Patient Health Questionnaire 9 (PHQ9) 21 to assess depression. Functional disability was defined as an HAQ-DI score >1.25. For the PHQ9, scores of 0-4 were considered normal, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, and 20-27 severe depression. Data were analyzed using SPSS 22. Percentages, means, and SDs were obtained. We used ANOVA and Student's t-test to compare the mean RAQoL scores between groups. We used the Pearson correlation coefficient to assess the correlation between numerical variables, given normal distribution of the data, which was evaluated by the Kolmogorov-Smirnov test with Lilliefors correction. Statistical significance was set at <0.05.
Results
A total of 186 patients completed the surveys: 89.8% were women and 10.2% men, with a mean age of 51±13.8 years. Regarding marital status, 49.5% patients were married, 17.2% free union, 16.1% single, 9.1% widow, and 8.1% divorced. Most patients (86%) came from urban areas. The main occupation was housework (52.7%), 42.5% had other jobs, and 4.8% didn't work, while 28% of patients were graduates, 11.3% undergraduates, and 60.7% had only school instruction.
Mean The mean ESR was 37.1±15.8 mm/h and CRP 14.5±12.8 mg/L. The mean DAS28 score was 3.1±1.4, and 42.5% patients were in remission, 16.7% had low disease activity, 33.9% moderate activity, and 7.0% high activity. As for other markers of disease activity, the mean painful-joint count was 2±4, swollen joints 2±4, VAS for pain 3.4±2.8, and physician´s assessment 2.7±2.5.
Regarding treatment, 68.8% used steroids, 66.7% methotrexate, 49.5% nonsteroidal anti-inflammatory drugs, 15.6% hydroxychloroquine, 8.1% biologics, 7% sulfasalazine, and 4.8% leflunomide. The mean HAQ-DI score was 0.8±0.8 and mean RAQoL score 7.2±7.8. The prevalence of functional disability was 26.9%. There were no significant differences in RAQoL scores in relation to demographics, as shown in Table 1 .
Patients with erosive disease had a mean RAQoL score of 9.6±8. In contrast, patients without erosions had a mean RAQoL score of 5.6±6 (p<0.05). Likewise, patients with morning stiffness >1 hour had a higher mean RAQoL score (8.5±8) than those without morning stiffness (6.0±6; p<0.05). We also found significant differences in RAQoL scores for xerophthalmia (8.5±8 with vs 5.9±7 without, p<0.05), xerostomia (8.6±8 with vs 6.1±7 without, p<0.05), fever (9.9±8 with vs 6.6±7 without, p<0.05), and fatigue (9.9±8 with vs 5.4±6 without, p<0.05).
RAQoL scores increased in relation to the number of comorbidities, as shown in Figure 1 (p<0.05). Patients with depression had a higher mean RAQoL score (12.4±8.7) than those without depression (3.4±4.2; p<0.05; Figure 2 ). RAQoL scores were higher in patients with higher disease activity ( Figure 3 ). Patients in remission had a mean RAQoL score of 3.7±5.2 versus 9.8±8.5 for those with active disease (p<0.05). Patients with functional disability had a mean RAQoL score of 15.6±8.3 versus 4.1±4.8 in patients without disability (p<0.05). RAQoL scores also showed positive correlations with ESR, CRP, painful-joint count, swollen-joint count, VAS for pain and physician assessment (p<0.05).
Discussion
This study showed that QoL in patients with RA is affected by many factors, such as pain, disease activity, disability, depression, fatigue, extra-articular manifestations, and comorbidities, as shown in previous literature. [7] [8] [9] [10] [11] The mean RAQoL score in our population was similar to that found in another study carried out in Ecuador and in other studies from other Latin American countries.
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Though we did not find associations between demographics and QoL, other authors have. Aurrecoechea et al 25 found that women had worse QoL than men. This is not surprising, as women tend to experience more pain, 26 show higher disease activity, 27 and have higher rates of disability, 28 all of which influence QoL. Wallenius et al 29 reported that a higher level of education was associated with better QoL, which could illustrate the role of patient knowledge and understanding about their condition in their ability to cope It has been established that physical function decreases with age 32 and that advanced age is related to lower QoL in patients with RA. 33 Conversely, Matcham et al 34 reported that higher mean age was associated with better QoL. This paradoxical association might be due to the impact that chronic diseases have on various aspects of life. Studies have shown that the effects of different diseases on work capacity, self-esteem, and maintenance of relationships are more debilitating to experience as a young adult. 35, 36 Unfortunately, in this study we did not find any association with age. A similar situation was found when analyzing the relation between disease duration and QoL. Several studies have linked longer disease duration with lower QoL. 6, 37 Matcham et al 34 found the opposite association, which could be explained by the fact that patients who experience symptoms for a longer time have a higher level of acceptance of their condition. In patients with RA, illness acceptance has been associated with lower anxiety and depression, and pain acceptance has been associated with better well-being. 38, 39 Disease activity, pain, disability, and QoL are interconnected factors. Carr et al 40 found that pain was the most influential factor in QoL in RA patients, especially during relapses. The pain accompanying RA contributes to patients becoming irritated, uncomfortable, anxious, and even isolated. Patients with higher disease activity usually have higher pain levels, which in turn is associated with higher rates of disability. 41 Marra et al 42 estimated that an increase of 0.25 in HAQ-DI score was associated with an increase of 2.0 on the RAQOL. The relationship between disability and QoL may be because patients with RA have greater physical dependence, which limits their ability to carry out normal activities and interact with their family, friends, and environment as they did before the disease. The effect of comorbidities on QoL depends on the number and type of comorbid conditions. Ranganath et al 11 demonstrated that each comorbidity decreases QoL in patients with RA by 28%. In Rupp et al, 43 the comorbidities with greatest impact on QoL were gastrointestinal, pulmonary, and cardiovascular diseases. Ozcetin et al 44 showed that psychiatric disorders, such as depression and anxiety, also have a significant influence on QoL. In this study, depression was the only comorbidity with a significant impact on QoL.
The factors that contribute to depression in patients with RA are pain, suffering from somatic symptoms, and functional limitations. 45 In turn, the presence of depression has been shown to be associated with worse health status and QoL. 
Conclusion
QoL is severely affected in patients with RA. Depression, fatigue, morning stiffness, pain, disease activity, and disability have a negative effect on QoL in RA. Improvement in these factors plays an important role in improving QoL in RA. The RAQoL constitutes an adequate questionnaire in patients with RA, and could easily be implemented in regular rheumatologist visits. Clinicians should facilitate patients with psychological and social support, in order to improve clinical outcomes.
The main limitation of this study was that most studies on QoL used other questionnaires, such as the SF36. As these other questionnaires have different scales, it is difficult to compare scores with the RAQoL. In addition, there is still no cutoff point to define good or bad QoL using the RAQoL.
